We've been dealing with this pandemic for nearly two years, so it's past time for further medicinal interventions. Sure enough, just as the Omicron form of COVID threatens to wreak havoc, two new antiviral medications are 'on the verge' of being made available to the general population – with Gauteng at the head of the line.
Jack Bloom is the province's shadow health MEC. As Omicron smashes through Gauteng, he has questioned the local administration on how they plan to curb the rising number of cases. However, his counterpart, Nomathemba Mokgethi, appears to be ahead of the game:
"As Gauteng faces an expanding fourth wave, two abroad medications that have showed promise as effective early treatments in overseas studies are being considered." This wonderful news was revealed today at a virtual session of the Gauteng Legislature by Gauteng Health MEC Nomathemba Mokgethi in an oral response to my questions."
"Paxlovid and Molnupiravir medications are being considered, according to Mokgethi, despite the fact that these pills have not yet been registered by the SA Health Products Regulatory Authority" (SAHPRA). The National Essential Medicines List Committee, according to Mokgethi, is looking into peer reviews in order to finalize clearance for the use of these pharmaceuticals in South Africa."
Both medicines can reduce your risks of ending up in a hospital or even a mortuary as a result of COVID-19. Section 21 of the Medicines Act allows SAHPRA to distribute drugs approved by an overseas regulatory authority. Merck and Pfizer have both expressed "the highest faith" in their antiviral products.
The two supposed "miracle medicines" under consideration are Merck's Molnupiravir and Pfizer's Paxlovid.
Molnupiravir has been demonstrated to cut the risk of hospitalization and mortality in half.
Paxlovid, on the other hand, claims to be 85 percent successful in averting the worst-case scenario.
The Paxlovid tablets were developed by Pfizer, a company that knows a thing or two about little medications.
Both medications must be administered within five days of the onset of symptoms.
Omicron has been a game-changer in recent weeks, and early evidence suggests it will reinfect those who have previously been infected with COVID-19.
Although those who have been fully jabbed have a high level of protection against serious sickness, those who have not been totally jabbed may catch this strain. These medications, on the other hand, are effective enough to boost antibody levels in those who are vulnerable.
What are your thoughts on the subject? Share your thoughts in the comments box below, and don't forget to follow my account for updates on and other topics. Please forward this article to your friends and family so they don't miss out on this important information.
Content created and supplied by: Owl24/7 (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More